Full Committee Hearing - FDA User Fee Agreements: Strengthening FDA and the Medical Products Industry for the Benefit of Patients
Date:
Thursday, March 29 2012, 10:00 AM
Place:
216 Hart Senate Office Building
Witnessesreturn to top
Panel I
-
Janet Woodcock, M.D. , Director, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD
-
Jeffrey Shuren, M.D., J.D. , Director, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, MD
Panel II
-
David Wheadon, M.D. , Senior Vice President of Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America, Washington, DC
-
Sara Radcliffe , Executive Vice President, Health, Biotechnology Industry Organization, Washington, DC
-
David R. Gaugh, R.Ph. , Vice President for Regulatory Affairs, Generic Pharmaceutical Association, Washington, DC
-
David Nexon, Ph.D. , Senior Executive Vice President, Advanced Medical Technology Association, Washington, DC
-
Allan Coukell, BScPharm , Director of Medical Programs, The Pew Charitable Trusts, Washington, DC
Recent News
- Harkin Statement on House Vote That Would Make College More Expensive for Millions of American Students [Chairman]
- Harkin Reintroduces FIT Kids Act to Combat Childhood Obesity and Promote Physical Activity [Chairman]
- Alexander Opposes Nominees to NLRB Who Remained on Board After Court Found Their Appointments Unconstitutional [Ranking Member]
- Senate Health Committee Passes Alexander and Colleagues’ Bill to Fix Responsibility for Safety of Sterile Compounded Drugs [Ranking Member]
- Harkin Statement on HELP Committee Approval of a Full Slate of Five Nominees to the NLRB [Chairman]
.jpg)
